ALX Oncology Holdings Inc.
ALXO
$1.93
-$0.08-3.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.97M | -17.93M | -22.85M | -22.14M | -25.95M |
| Total Depreciation and Amortization | 564.00K | 150.00K | 151.00K | 153.00K | 714.00K |
| Total Amortization of Deferred Charges | 66.00K | 68.00K | 72.00K | 72.00K | 69.00K |
| Total Other Non-Cash Items | 771.00K | 2.70M | 2.91M | 2.70M | 4.93M |
| Change in Net Operating Assets | 513.00K | -3.64M | 739.00K | 2.12M | -3.17M |
| Cash from Operations | -16.06M | -18.65M | -18.98M | -17.09M | -23.41M |
| Capital Expenditure | -17.00K | -50.00K | -49.00K | -56.00K | -47.00K |
| Sale of Property, Plant, and Equipment | 44.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.50M | -104.99M | 11.28M | 21.45M | 22.36M |
| Cash from Investing | 6.52M | -105.04M | 11.23M | 21.39M | 22.32M |
| Total Debt Issued | 10.00M | -- | -- | -- | -- |
| Total Debt Repaid | -1.54M | -1.61M | -660.00K | -160.00K | -237.00K |
| Issuance of Common Stock | 107.00K | 150.67M | 22.00K | 1.00K | 15.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.43M | -9.47M | 1.32M | 0.00 | 0.00 |
| Cash from Financing | 137.00K | 139.60M | 678.00K | -159.00K | -222.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.40M | 15.91M | -7.07M | 4.14M | -1.31M |